Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Southwest Oncology Group study 8712

Invest New Drugs. 1993 Feb;11(1):45-6. doi: 10.1007/BF00873909.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular / drug therapy*
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / therapeutic use*
  • Female
  • Humans
  • Infusions, Intravenous
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Trimetrexate / adverse effects
  • Trimetrexate / therapeutic use*

Substances

  • Drugs, Investigational
  • Trimetrexate